Yilmaz, MEKiraz, MKara, IH2024-04-242024-04-2420000090-2934https://hdl.handle.net/11468/21445Our purpose was to determine serum zinc (Zn) and copper (Cu) levels in patients with chronic renal failure (CRF) undergoing hemodialysis (HD) and to investigate the influence of HD duration on these trace elements. The study group included 26 HD patients and a control group of 26 healthy subjects. Blood samples were drawn for determination of serum Zn and Cu levels, which were measured by atomic absorption spectrophotometry. The mean age was 43 +/- 15 yr in the HD group, and 40 +/- 17 yr in the control group. Laboratory findings showed the following mean values: Zn 69.6 +/- 17.6 mug/dl in the HD group (vs. 114.6 +/- 34.3 mug/dl in the control group); Cu, 85.3 +/- 14.8 mug/dl in the HD group was significantly lower than that of the control group (p<0.0001). The serum Cu level of the HD group was also significantly lower than that of the control group (p<0.0001), but was in the normal range. Statistically, we didn't find any significant differences in the serum Zn and Cu levels between long-term and short-term dialyzed patients (p>0.05). Because the serum Zn level of the HD group was significantly low, we recommend that Zn should be given to patients with CRF undergoing HD.eninfo:eu-repo/semantics/closedAccess[No Keyword]Article2911718+WOS:0001650566000072-s2.0-0033765242N/AQ4